⌘K

Login Start Free

Home/Filings/4/0000874015-25-000252

4//SEC Filing

Monia Brett P 4

Accession 0000874015-25-000252

CIK 0000874015other

View on SEC.gov Company Profile

Filed

Oct 7, 8:00 PM ET

Accepted

Oct 8, 6:36 PM ET

Size

4.7 KB

Accession

0000874015-25-000252

Insider Transaction Report

Form 4

Period: 2025-10-06

IONIS PHARMACEUTICALS INCIONS

DirectorChief Executive Officer

Transactions

Sale
Common Stock
2025-10-06$69.26/sh−437$30,268→ 179,572 total

Footnotes (1)

[F1]Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on August 13, 2024.

Documents

1 file

4
edgardoc.xmlPrimary
PRIMARY DOCUMENT

Issuer

IONIS PHARMACEUTICALS INC

CIK 0000874015

Entity typeother

Related Parties

1

filerCIK 0001537529

Filing Metadata

Form type: 4
Filed: Oct 7, 8:00 PM ET
Accepted: Oct 8, 6:36 PM ET
Size: 4.7 KB

View on SEC.gov